Heart failure in women

Area of Science:

• Cardiology
• Sex Differences in Medicine
• Cardiovascular Research

Background:

• Women with heart failure (HF) are underrepresented in clinical trials, leading to knowledge gaps.
• Existing diagnostic criteria for HF in women have varied, complicating epidemiological studies.
• Understanding sex-specific differences in HF is crucial for effective diagnosis and treatment.

Purpose of the Study:

• To describe the distinct differences between women and men regarding heart failure.
• To explore the influence of sex hormones, aging, and injury responses on HF development in women.
• To identify key risk factors and treatment responses specific to women with HF.

Main Methods:

• Review of existing literature on sex differences in heart failure.
• Analysis of epidemiological data and clinical trial participation.
• Examination of physiological mechanisms including hormonal effects and responses to cardiovascular stress.

Main Results:

• Hypertension, diastolic dysfunction, diabetes, obesity, and inactivity are more prevalent risk factors in women.
• Ischemic heart disease and systolic dysfunction are more significant in men.
• Women may experience less benefit from current HF treatments but demonstrate better overall survival rates.

Conclusions:

• Sex hormones, aging, and injury responses contribute to observed differences in HF epidemiology, risk factors, and mechanisms between sexes.
• Established treatments for heart failure may have differential efficacy in women.
• Future research dedicated to women's cardiovascular health is essential to optimize HF management and outcomes.